Campaign Launches to Educate on HA Injectable Fillers
The initiative features a new report with data on consumer satisfaction and trends, aiming to correct misinformation for patients and providers.
The initiative features a new report with data on consumer satisfaction and trends, aiming to correct misinformation for patients and providers.
The cellulose-based dermal filler has received Health Canada authorization to begin clinical trials evaluating its safety and performance in tissue augmentation.
The treatment is the first short-duration facial injectable available in the region for the temporary improvement of lines between the eyebrows.